Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
31/07/2026 08:09
BRIEF-Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees July 31 (Reuters) - Strides Pharma Science Ltd SRID.NS:
STRIDES PHARMA SCIENCE JUNE-QUARTER CONSOL NET PROFIT 1.57 BILLION RUPEES
STRIDES PHARMA SCIENCE JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 12.65 BILLION RUPEES
Source text: ID:nnAZN4TB25V
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees